We are live on ! Find out more
RDHL

Redhill Biopharma

11 hedge funds and large institutions have $103K invested in Redhill Biopharma in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

112% more capital invested

Capital invested by funds: $48.8K → $103K (+$54.7K)

0% more funds holding

Funds holding: 1111 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.03% less ownership

Funds ownership: 0.03%0% (-0.03%)

Holders
11
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

RDHL Hedge Fund Activity: Q4 2024 in Review

11 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2024, worth a combined $103K — up 112% from $48.8K a quarter earlier.

Fund positioning in RDHL was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was GAMMA Investing, opening a new position worth an estimated $38.9K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $4.62K.

  • 11 institutional investors held Redhill Biopharma (RDHL) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $103K of Redhill Biopharma stock for Q4 2024, up 112% quarter-over-quarter.
  • 3 funds opened new Redhill Biopharma positions in Q4 2024 and 3 closed out, a net change of 0 holders.
  • The largest Redhill Biopharma buyer in Q4 2024 was GAMMA Investing, an estimated $38.9K added.
  • The largest Redhill Biopharma seller in Q4 2024 was Federation des caisses Desjardins du Quebec, an estimated $4.62K sold.

Based on aggregated 13F filings for Q4 2024.